ARYLIMINOTHIAZOLE DERIVATIVES OF COUMARIN
1305
7. Anklekar, K. Y.; Lakkannavar, C. D.; Kulkarni, G. M.; Kulkarni, M. V. Synthesis, spectral
studies, and biological evaluation of some new 4-substituted coumarins. Indian J. Chem.
2003, 42B, 1548–1550.
8. Purohit, N. V. Synthesis and studies on biological activities of some substituted 2-benzo
pyran-1H-one, 1H-2-oxo-benzopyran-3-carboxylic acids and 2-benzofuran-1(H)-one,
Indian J. Chem. 2001, 40B, 222–227.
9. Nawrot, M. J.; Nawrot, E.; Graczyk, J. In vivo antitumor, in vitro antibacterial activity, and
alkylating properties of phasphorohydrazine derivatives of coumarin and chromone. Eur.
J. Med. Chem. 2006, 41, 1301–1309.
10. Kostova, I. Synthetic and natural coumarins as cytotoxic agents. Curr. Med. Chem. Anti
Canc. Agents. 2005, 5, 29–46.
11. Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Hughes, S. H.; John, H. C.; McMahon, J. B.;
Currens, M. J.; Buckheit, R. W.; Hughes, S. H.; Cragg, G. M.; Boyd, M. R. The calanoids,
a novel HIV inhibitory class of coumarin derivatives from the tropical rain forest tree,
Calophyllum lanigerum. J. Med. Chem. 1993, 36, 1110–1110.
12. Sandhya, B.; Vinod, M.; Lolitha, P.; Aswini, T.; Shravani, A. Synthesis, characteriza-
tion, and pharmacological activities of coumarin derivatives. Int. J. Pharm. Sci.2011, 1,
17–25.
13. Bullock, S. J.; Felton, C. E.; Fennessy, R. V.; Harding, L. P.; Andrews, M.; Pope, S. J. A.;
Rice, C. R.; Riis-Johannessen, T. Coumarin-based luminescent ligand that forms helicates
with dicationic metal ions. Dalton Trans. 2009, 47, 10570–10573.
14. Ghazaryan, A.; Khatchadouria, A.; Karagyozyan, M.; Kachatryan, A.; Sekoyan, E.;
Bdoyan, H.; Melkumyan, H.; Karageuzyan, K. Peculiarities of the anticoagulant proper-
ties for the newly synthesized preparations of coumarin-related compounds. Cardiovasc.
Hematol. Disord. Drug Targets. 2007, 7, 170–173.
15. Kancheva, V. D.; Boranova, P. V.; Nechev, J. T.; Manolov, I. I. Structure–activity relation-
ships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxi-
dants. Biochimie 2010, 92, 1138–1146.
16. Morabito, G.; Domenico, T.; Singh Brajendra, K.; Prasad Ashok, K.; Parmar Virinder, S.;
Clara Naccari, F. M.; Saija, A.; Cristani, M.; Firuzio, O.; Saso, L. Antioxidant properties
of 4-methyl coumarins in in vitro cell-free systems. Bio chimie 2010, 92, 1101–1107.
17. Grimm, E.; Brideau, C., Chauret, N.; Chan, C.; Delorme, D.; Ducharme, Y.; Ethier, D.;
Falgueyret, J. P.; Friesen, R. W.; Joucelyne, G.; Hamel, P.; Denis, R.; Breau, C. S.; Philip, T.;
Girard, Y.; Guay, J. Substituted coumarins as potent 5-lipoxygenase inhibitors. Bio org.
Med. Chem. Lett. 2006, 16, 2528–2531.
18. Resch, M.; Steigel, A.; Chen, Z.-L.; Bauer, R. 5-Lipoxygenase and cyclooxygenase inhibi-
tory active compounds from Atractylodes lance. J. Nat. Prod. 1998, 61, 347–350.
19. Liu, H.-L.; Li, Z.; Anthonsen, T. Synthesis and fungicidal activity of 2-imino-3-(4-
arylthiazol-2-yl)-thiazolidin-4-ones and their 5-arylidene derivatives. Molecules 2000, 5,
1055–1061.
20. Sham, M. S.; Amrender, D. D.; Jaiveer, S.; Guptha, P. P. Synthesis and anti-inflammatory
activity evaluation of some sulfonamides, amidines, and thiazoline derivatives. Indian J.
Chem. 2010, 49B, 1076–1082.
21. Aamer, S.; Najim, A.; Chrisopher, P. In-vitro anti-HIV activity of new thiazol-2-ylidine
substituted benzamide analogues. Pharm. Chem. 2012, 4(1), 106–115.
22. Sondhi, S. M.; Singh, N.; Lahoti, A. M.; Kiran, B.; Ashok, K.; Lozach, O.; Meijer, L.
Synthesis of acridinyl-thiazolino derivatives and their evaluation for anti-inflammatory,
analgesic, and kinase inhibition activities. Bio-org. Med. Chem. 2005, 13, 4291–4299.
23. Kim, D. S.; Jeong, Y. M.; Park, I. K.; Hahn, H. G.; Lee, H. K.; Kwon, S. B.; Jeong, J. H.;
Yang, S. J.; Sohn, U. D.; Park, K. C. A new 2-imino-1,3-thiazoline derivative, KHG 22394,
inhibits melanin synthesis in mouse B16 melanoma cells. Biol. Pharm. Bull. 2007, 30,
180–183.